{"groups":[{"description":"Patients undergo biopsy along with tumor mutational screening of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Patients also undergo collection of blood samples for research purposes.","id":"FG000","title":"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"903"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"25"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"27"}],"type":"Physician Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"15"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"16"}],"type":"Ineligible"},{"reasons":[{"groupId":"FG000","numSubjects":"25"}],"type":"5th anniversary of the most recent date of patient enrollment onto a subprotocol"},{"reasons":[{"groupId":"FG000","numSubjects":"348"}],"type":"Two years from date of patient enrollment onto APEC1621SC if not enrolled onto a subprotocol"},{"reasons":[{"groupId":"FG000","numSubjects":"6"}],"type":"Two years from date of technical failure"},{"reasons":[{"groupId":"FG000","numSubjects":"12"}],"type":"Still On Study/in Follow-Up on APEC621SC"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1377"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1377"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}